The trading price of Jade Biosciences Inc (NASDAQ:JBIO) closed lower on Monday, May 05, and closing at $11.50, -7.85% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $92.46 and a 52-week low of $4.57. Over the past month, the stock has gained 25.29% in value.
Jade Biosciences Inc, whose market valuation is $370.71 million at the time of this writing, is expected to release its quarterly earnings report in June. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest JBIO has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 50% Sell.
A quick review shows that JBIO’s price is currently 15.19% off the SMA20 and 21.76% off the SMA50. The RSI metric on the 14-day chart is currently showing 65.23, and weekly volatility stands at 26.16%. When measured over the past 30 days, the indicator reaches 9.99%. Jade Biosciences Inc (NASDAQ:JBIO)’s beta value is currently sitting at 0.96, while the Average True Range indicator is currently displaying 1.06.
To see how Jade Biosciences Inc stock has been performing in comparison to its peers in the industry, here are the numbers: JBIO stock’s performance was -7.85% in the latest trading, and -84.91% in the past year.
An evaluation of the daily trading volume of Jade Biosciences Inc (NASDAQ:JBIO) indicates that the 3-month average is 94.68K.
Currently, records show that 0.83 million of the company’s shares remain outstanding. The insiders hold 27.11% of outstanding shares, whereasinstitutions hold 77.56%. However, since the stock’s price has seen 18.68% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
